Oracle Health Sciences and Trial Master File (TMF) technology provider Phlexglobal have collaborated to accelerate the speed and accuracy of regulatory compliance, as well as inspection readiness in clinical trials.

A TMF is a requirement that should be satisfied by all sponsors and contract research organisations (CROs) to assure that the rights, safety and well-being of trial participants are protected.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

CROs and sponsors should also check if the trials are being conducted in accordance with good clinical practice (GCP)  principles, and enhance the audit readiness of clinical data.

Oracle Health Sciences noted that Phlexglobal’s PhlexEview TMF management system uses automation to streamline processes.

The TMF system has an open architecture to ensure easy data integration, and provides advanced functionality designed to facilitate TMF Management in a more efficient manner.

Phlexglobal CEO John McNeill said: “Our integration with Oracle Health Sciences’ industry-leading applications will save organisations significant resources, as documents only have to be checked once early in the process, which will ensure that any issues can be found and corrected in a timely manner enhancing overall quality.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“Our life science customers will be able to leverage industry KPIs to support business process optimisation and business intelligence in clinical study startup, strengthening our regulatory compliance and global trial oversight capabilities.”

The Oracle Health Sciences eClinical platform, when integrated with the TMF, provides an advanced clinical trial ecosystem for life sciences companies.

Oracle Health Sciences life sciences product strategy global vice-president James Streeter said: “Adoption of industry standards is critical to plug-and-play coexistence in the eClinical ecosystem.

“What’s required is a deep understanding of the right type of integration at the right time for the different integration points.

“The TMF Reference Model Exchange Mechanism facilitates these integrations by providing a common language amongst all eClinical vendors. We strongly support this initiative.”

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact